What can the plasma proteome tell us about platelets (and vice versa)? by Bruzek, Steven, Betensky, Marisol, Di Paola, Jorge, Diacovo, Thomas, Goldenberg, Neil, Ignjatovic, Vera

Get full text

Plasma Hypercoagulability and Hypofibrinolysis Are Associated with Increased Markers of Inflammation in Pediatric VTE: Findings from the Kids-DOTT Trial Biobank by Betensky, Marisol, Goldenberg, Neil, Ignjatovic, Vera, Mosha, Maua, Bruzek, Steven

Get full text

Whole-Genome Sequencing for Bacterial Strain Typing Using the iSeq100 Platform by Vestal, Grant, Bruzek, Steven, Lasher, Amanda, Lima, Amorce, Silbert, Suzane

Get full text

Evaluation of the bioMérieux EPISEQ-CS Software for wgMLST-Based Bacterial Strain Typing by Lima, Amorce, Bruzek, Steven, Lasher, Amanda, Vestal, Grant, Silbert, Suzane

Get full text

Methods, precision, and analytical sensitivity of a novel low‐plasma‐volume assay of fibrinolytic capacity utilizing the euglobulin fraction by Bruzek, Steven, Betensky, Marisol, Sochet, Anthony A., Goldenberg, Neil A., Ignjatovic, Vera

Get full text

Optimization of cell receptor-specific targeting through multivalent surface decoration of polymeric nanocarriers by D'Addio, Suzanne M., Baldassano, Steven, Shi, Lei, Cheung, Lila, Adamson, Douglas H., Bruzek, Matthew, Anthony, John E., Laskin, Debra L., Sinko, Patrick J., Prud'homme, Robert K.

Get full text

Posterior Cranial Vault Distraction Osteogenesis: Routine Low Occipital Craniotomy Is a Safe Approach That Optimizes Outcomes by Ulma, Raquel M., Sacks, Gina, Bruzek, Amy K., Vercler, Christian J., Muraszko, Karin, Buchman, Steven R.

Get full text

A Phase I Trial of the Farnesyl Protein Transferase Inhibitor R115777 in Combination with Gemcitabine and Cisplatin in Patients with Advanced Cancer by ADJEI, Alex A, CROGHAN, Gary A, BRUZEK, Laura M, ATHERTON, Pamela, THIBAULT, Alain, PALMER, Peter A, KAUFMANN, Scott H, ERLICHMAN, Charles, MARKS, Randolph S, REID, Joel M, SLOAN, Jeff A, PITOT, Henry C, ALBERTS, Steven R, GOLDBERG, Richard M, HANSON, Lorelei J

Get full text

A Phase I and Pharmacologic Trial of Two Schedules of the Proteasome Inhibitor, PS-341 (Bortezomib, Velcade), in Patients with Advanced Cancer by DY, Grace K, THOMAS, James P, HANSON, Lorelei J, MARNOCHA, Rebecca, TUTSCH, Kendra, KAUFMANN, Scott H, ADJEI, Alex A, WILDING, George, BRUZEK, Laura, MANDREKAR, Sumithra, ERLICHMAN, Charles, ALBERTI, Dona, BINGER, Kim, PITOT, Henry C, ALBERTS, Steven R

Get full text

Identifying markers for pancreatic cancer by gene expression analysis by Zhou, W, Sokoll, L J, Bruzek, D J, Zhang, L, Velculescu, V E, Goldin, S B, Hruban, R H, Kern, S E, Hamilton, S R, Chan, D W, Vogelstein, B, Kinzler, K W

Get full text

A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade™), in combination with paclitaxel and carboplatin in patients with advanced... by MA, Cynthia, MANDREKAR, Sumithra J, ERIICHMAN, Charles, WRIGHT, John J, ADJEI, Alex A, ALBERTS, Steven R, CROGHAN, Gary A, JATOI, Aminah, REID, Joel M, HANSON, Lorelei J, BRUZEK, Laura, TAN, Angelina D, PITOT, Henry C

Get full text